|
|
Volumn 19, Issue 8, 2004, Pages 516-518
|
|
Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine
|
|
Author keywords
Atypical antipsychotics; Olanzapine; Outpatients; Randomised trial; Schizophrenia
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZODIAZEPINE;
BIPERIDEN;
CHLORPROMAZINE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DIAZEPAM;
HYPNOTIC AGENT;
MONOAMINE OXIDASE INHIBITOR;
NEUROLEPTIC AGENT;
OLANZAPINE;
PSYCHOTROPIC AGENT;
ZALEPLON;
ZOLPIDEM;
ZOPICLONE;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DRUG SAFETY;
FEMALE;
HUMAN;
MALE;
NEUROLOGIC DISEASE;
OUTPATIENT;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PSYCHOSIS;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
SCHIZOPHRENIA;
SIDE EFFECT;
SYMPTOM;
SYMPTOMATOLOGY;
ADULT;
AMBULATORY CARE;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
CHLORPROMAZINE;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
SCHIZOPHRENIA;
|
|
EID: 10044289536
PISSN: 09249338
EISSN: None
Source Type: Journal
DOI: 10.1016/j.eurpsy.2004.06.035 Document Type: Article |
|
Times cited : (15)
|
|
References (8)
|
